Recognizing and Responding to Serious Safety Concerns with Subcutaneous Insulin

 
A Midday Symposium conducted at the 49th ASHP Midyear Clinical Meeting and Exhibition

Tuesday, December 9, 2014 - 11:30am-1:00pm PST
Hilton Anaheim, California Ballroom D
Click here to register to attend

Overview

A 2014 survey by the Institute for Safe Medication Practices (ISMP) suggests that pharmacists and nurses believe hospitalized patients are more vulnerable to errors with subcutaneous insulin than with any other high-alert drug, and that more must be done to prevent patient harm with this high-alert medication. This symposium will address categories of risk with subcutaneous insulin preparation and administration that have been overlooked in healthcare organizations, including risks associated with pens, needles, syringes, and vials; use of sliding scale insulin; and patient assessment, monitoring, and education. Speakers will describe how pharmacists can help prevent insulin related medication errors and other adverse outcomes.

Objectives

The target audience for this activity includes pharmacists in health-system settings. At the completion of this symposium, the participant should be able to:

• List the challenges in prescribing, preparing, and dispensing insulin.
• Define the best practices for the use of insulin in hospitalized patients.
• Describe strategies for safely managing the use of insulin pens.
• Identify emerging products and best practices for the use of concentrated insulin.
• Describe educational goals for hospitalized diabetic patients and how to meet them.

Agenda

10:45am - Doors Open
11:30am-1:00pm - Symposium
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis.

Food and beverage are no longer provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.

Topics and Faculty

Introduction and Program Overview
Christina Michalek, RPh, BS, FASHP
Medication Safety Specialist, ISMP

Risks Associated with Pens, Needles, Syringes, and Vials
Michael R. Cohen, RPh, MS, ScD, FASHP
President, ISMP

Risks Associated with Use of Sliding-Scale and Concentrated Insulin
Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE
Assistant Director of Experiential Education, Associate Professor of Pharmacy Practice,
Midwestern University Chicago College of Pharmacy, Downers Grove, IL

Risks Associated with Patient Assessment, Monitoring, and Education
Matthew Grissinger, RPh, FISMP, FASCP
Director of Error Reporting Programs, ISMP

CE Accreditation

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-14-230-L05-P has been assigned to this knowledge-based live CE activity (initial release date December 9, 2014). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 9, 2015 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor within 1 to 2 weeks of the completion of the posttest and evaluation. No partial credit will be given.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Cohen has no relevant commercial or financial relationships to disclose. Dr. Cornell has no relevant commercial or financial relationships to disclose. Mr. Grissinger has no relevant commercial or financial relationships to disclose. Ms. Michalek has no relevant commercial or financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

Funding

This symposium is funded through an educational grant from BD.